Insider Stock Trading History of Kenyon Lawrence A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kenyon Lawrence A since year 2005. The trader's CIK number is 1230484. At the time of this reporting, Kenyon Lawrence A is the CEO, Pres, CFO, Treas & Secy of Outlook Therapeutics, Inc. . (stock ticker symbol OTLK). See this page for all insider trading activities at Outlook Therapeutics, Inc. .

Note that in the past KENYON LAWRENCE A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Kenyon Lawrence A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-02-07 OTLK Outlook Therapeutics, Inc. Buy 25,000 .90 22,375
2018-09-18 ONS Outlook Therapeutics, Inc. Sale 10,100 .87 8,807
2017-12-22 ONS Outlook Therapeutics, Inc. Sale 26,165 1.13 29,566
2010-03-03 PRX Par Pharmaceutical Companies, Inc. Sale 21,439 25.22 540,713
2010-03-03 PRX Par Pharmaceutical Companies, Inc. Option Ex 21,439 13.06 279,993
2007-04-11 ACEL Alfacell Corp Buy 25,000 2.16 53,900

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kenyon Lawrence A (CEO, Pres, CFO, Treas & Secy of Outlook Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.